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A B S T R A C T
A human intervention in 24 healthy volunteers was performed to test the potential health benefits of a fermented
salami with a probiotic Lactobacillus rhamnosus HN001 and added citrus fiber. Anthropometric measurements
and blood biochemistry did not show any significant differences between pre- and post-intervention during
4 weeks with a daily intake of 30 g of salami, neither with regular salami (control group) nor with reformulated
salami (intervention group). However, the inflammatory markers CRP and TNFα decreased significantly after
intervention, suggesting a less inflammatory environment after reformulated salami consumption. Antioxidant
plasmatic markers also improved within the intervention group. Butyrate production was significantly increased
after reformulated salami consumption. Gut microbiota community structure, however, was not significantly
shaped by neither regular nor reformulated salami. After the intervention with probiotic salami, L. rhamnosus
was detected by quantitative polymerase chain reaction (qPCR) in all samples of the intervention group but not
in the control group, showing probiotic effect.
1. Introduction
Salami is a dry-fermented sausage consisting of mixtures of lean
meats and fatty tissues combined with salts, nitrate (curing agent),
sugars and spices filled into casings to undergo a microbial fermenta-
tion, drying and maturation process (FAO, 2019). Salami is often con-
sidered as a food with unbalanced nutritional value due to the high fat
and salt content and lack of bioactive molecules (Martínez, Nieto, &
Ros, 2014). However, salami is highly consumed around the world,
which could explain why in the last decade there has been a great focus
of interest on improving meat products quality through (Blaiotta,
Murru, Cerbo, Romano, & Aponte, 2018): (i) modifying meat products
formulation by adding functional ingredients (Olmedilla-Alonso,
Jiménez-Colmenero, & Sánchez-Muniz, 2013); (ii) modifying meat
composition through cattle feeding (Gilmore et al., 2011); (iii) by in-
novations in processing/storage conditions (Cullere, Hoffman, & Dalle
Zotte, 2013).
A major focus of interest was on the fat profile of meat products,
which led to several attempts to improve it. Although there is much
evidence that saturated fats are not to blame for cardiovascular diseases
(CVD), changing them for unsaturated fats appears to be beneficial
(Ekmekcioglu et al., 2018; de Souza et al., 2015). Accordingly, there
were several research projects, involving human interventions, that
were focused on achieving a healthier plasmatic lipid profile by in-
creasing monounsaturated fatty acids and polyunsaturated fatty acids
(MUFA and PUFA) content (Gilmore et al., 2011; Haug, Nyquist, Mosti,
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Andersen, & Høstmark, 2012) and adding plant sterols (Tikkanen et al.,
2001). In these cases, human interventions showed an improved plas-
matic lipid profile after consuming the reformulated meat product.
Moreover, substitution of fats by dietary fiber has also been attempted
(Verma & Banerjee, 2010). However, in such cases the focus of interest
was usually on physico-chemical properties and organoleptic attributes
of the product rather than in potential health benefits.
Fermented meat products have been also proposed as good carriers
for probiotics (Vuyst, Falony, & Leroy, 2008), which are expected to
play a role in host health. Recently, Thøgersen et al. (2018) studied the
addition of inulin on Frankfurt sausages fed to rats and their effect on
gut microbiota composition and short chain fatty acids (SCFAs) pro-
duction (Thøgersen et al., 2018). They observed that rats fed with
sausages enriched with inulin had an increased production of SCFA and
higher abundances of Bifidobacterium spp. in their gut. However, related
human studies are scarce and inconclusive. For instance, Jahreis et al.
(2002) found that consumption of fermented sausages with a probiotic
strain did not modify human lipid profile and the probiotic bacteria
were only identified in some volunteers’ feces (Jahreis et al., 2002).
Taking all this information into account, in this trial we aim to in-
vestigate the effects of the ingestion by healthy volunteers of 30 g/day
(during 4 weeks) of salami supplemented with fiber and a probiotic
starter on blood biochemistry, anthropometry, immunological markers,
fecal microbiota composition, SCFAs production, and antioxidant ca-
pacity of plasma and feces.
2. Materials and methods
2.1. Subjects and trial design
Twenty-four healthy subjects were recruited in the University of
Granada. Subjects were 20–30 years old and had a body mass index
(BMI) within normal range (18.5–25). The trial consisted of a long-
itudinal nutritional intervention, double-blinded, with placebo and two
parallel groups: control and intervention group (Fig. S1). Subjects were
asked not to consume probiotics during a week before starting the trial.
Participants were randomly divided into control and intervention
groups (n = 12 for each group). The control group was given regular
salami and instructed to intake 30 g/day (serving size) for 4 weeks. The
intervention group was given the reformulated salami and instructed to
intake 30 g/day for the same period of time. Both groups were given an
isocaloric diet along the intervention period in order to assure the
homogeneity of foods eaten. The day before starting the intervention,
fecal and blood samples were taken and anthropometric measurements
were also performed. At the end of the follow-up period, the same
samples and measurements were obtained.
The trial complied with the principles of the declaration of Helsinki.
The Ethics Committee of the University of Granada approved the trial
protocol (SA/17/AYU/246) and informed consent was obtained from
all participants.
2.2. Salami preparation
Salami samples were manufactured and provided by a local Spanish
company (Elpozo Alimentación, S.A., Alhama de Murcia, Murcia). Each
salami sample was formulated according to the following traditional
recipe: a mixture of pork meat and fatty tissues was combined with salt,
curing salt agent, black pepper, starch/fiber, and typical Mediterranean
herbal extract.
For the control salami, 2% w/w of starch was added, and a standard
starter composed of non-probiotic strains of lactic acid bacteria and
catalase-positive streptococci was applied (Lactobacillus fermentum and
Staphylococcus xylosus). Fiber-added salamis were supplemented with
the probiotic Lactobacillus rhamnosus HN001 as a starter culture, and
citrus fiber (obtained from orange pulp dehydration and composed of
42% pectin, 25% cellulose and hemicellulose, and acquired from
Fiberstars, USA). Fiber was added in a 1.5% w/w ratio. A mix of anti-
oxidant herbal extract, composed of olive, coffee and tea extracts was
also incorporated as ingredient in the improved salami (0.3% w/w),
which is the usual proportion for seasoning in sausages and the one
used by the company that provided the samples in their other com-
mercial products (Table 1). Fiber and herbal extract were chosen after
an in vitro test previously published (Pérez-Burillo et al., 2019). Salamis
were put into casings to exclude oxygen and subjected to a ripening-
drying process for 40 days. After curing, salamis were sliced and
packaged as they are for commercial purposes.
2.3. Anthropometric measurements
Guidelines of the International Society for the Advancement of
Kinanthropometry (ISAK) were followed for the anthropometric ana-
lysis (Stewart, Marfell-Jones, Olds, & Ridder, 2011). All anthropometric
measurements were carried out at the same place by an ISAK-certified
level II anthropometry researcher. The following instruments were
used: GPM Stadiometer ( ± 1 mm accuracy); Tefal scale ( ± 50 g ac-
curacy); Holtain skinfold compass ( ± 1 mm accuracy); Holtain caliper
( ± 1 mm accuracy); Holtain flexible metallic metric belt ( ± 1 mm
accuracy). The following measurements were taken: height, weight,
skinfolds (triceps, biceps, subscapular, suprailiac, supraspinal, abdom-
inal, thigh, and calf), perimeters (waist, hip, relaxed biceps, flexed and
contracted biceps, anckle, forearm, chest, thigh and calf, and waist/hip
index), and diameters (bicromial, biliocrestal, bicondylar humerus,
bistiloid and bicondylar femur). The body mass index (BMI) was cal-
culated from height and weight. Then, the percentages of fat mass, non-
fat mass and water were calculated. Bone density, and visceral fat was
also calculated along with the basal metabolism.
2.4. Blood biochemistry
Venous blood was used to determine health-related biochemical
markers. The analysis was performed in the morning after a 12-hour
fasting period. The samples were stored in the dark in containers with
ice and processed within the hour after extraction. Plasma was sepa-
rated by centrifugation at 1500 rpm for 20 min at 18–25 °C. The fol-
lowing parameters were measured with an automatized blood bio-
chemistry system (DiaSys Diagnostric Systems GmbH, Germany):
glycaemia (GL; mg/dL), total cholesterol (TC; mg/dL), HDL cholesterol
(cHDL; mg/dL), LDL cholesterol (cLDL; mg/dL) and triglycerides (TG;
mg/dL), urea (mg/dL), creatinin (mg/dL), uric acid (mg/dL), total
proteins (g/dL), alanine aminotransferase (ALT) and aspartate transa-
minase (AST, U/L), GGT (gamma-glutamyltransferase, U/L), alkaline
phosphatase (U/L), total billirrubine (mg/dL) and iron (μg/dL).
Table 1
Composition of each salami formulation.
Control salami Fiber added-supplemented salami
Nutrient Content, in g/100 g Content, in g/100 g
Energy, kcal 333 326
Water, g 37.9 37.9
Protein, g 25.8 26.5
Lipids, g 22.9 22.1
Saturated, g 7.2 6.8
Monounsaturated, g 11.7 11.4
Polyunsaturated, g 3.9 3.8
Carbohydrates, g 3.2 3.3
Starch, g 2.0 0.0
Fiber, g 0.0 1.5
Herbal extract, g 0.0 0.3
Ash, g 4.2 4.4
Regular culture strains 59 510
L. rhamnosus HN001 0.0 210
Regular culture strains: S. xylosus and L. fermentum.
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Oxidized LDL was measured through an ELISA kit (OxiSelect™ Human
Oxidized LDL ELISA Kit, Cell Biolabs, Inc. USA).
Haematology was assessed through the following parameters: leu-
kocytes (x103/μL), red blood cells (x106/μL), haemoglobin (g/dL),
haematocrit (%), MCV (Mean Corpuscular Volume, fL), MCH (Mean
Corpuscular Haemoglobin, pg) and MCHC (Mean Corpuscular
Hemoglobin Concentration, g/dL). Leukocyte formula was also as-
sessed: platelets (×103/μL), neutrophils, eosinophils, basophils, lym-
phocytes and monocytes (%).
2.5. Inflammatory and immunological markers
Venous blood was also used to analyze and quantify inflammatory
and immunological markers. Tumor Necrosis Factor alpha (TNFα),
Interleukin 6 (IL-6) and Interleukin 10 (IL-10) were measured through
their corresponding ELISA kits from Thermo Fisher scientific (USA). C-
Reactive Protein (CRP) was measured through the Human C-Reactive
Protein ELISA Kit (CLIA) from Biomatik (USA). Phagocytic activity was
measured as described in Gill and Rutherfurd (2001).
2.6. Fecal antioxidant capacity and plasma antioxidant status
The FRAP assay was used to measure the antioxidant capacity of
feces, according to the procedure described in Benzie and Strain (1996).
Results were expressed as mmol Trolox/g of sample.
Catalase (CAT) activity in plasma was determined following the
method described by Pastoriza, Roncero-Ramos, Rufián-Henares, and
Delgado-Andrade (2014). Results were expressed as μmol H2O2/min/
mL.
Glutathione peroxidase (GPX) activity in plasma was determined as
described in Pastoriza et al. (2014). Results were expressed as μmol
GSH/min/mL.
Malondialdehyde (MDA) analysis in plasma was carried out as
stated in Olusi (2002). Results were expressed as μmol MDA/L.
2.7. SCFAs analysis
The production of SCFAs was measured in feces and it was assessed
by HPLC according to the procedure described in Pérez-Burillo et al.
(2019). Results were expressed as mmol/kg of feces.
2.8. DNA extraction and sequencing
Fecal microbial ecology was assessed by analyzing the 16S rRNA
gene. To do that, DNA extraction, sequencing and bioinformatics ana-
lyses were performed as described in Pérez-Burillo et al. (2019). DNA
extraction was performed using a NucliSENS easyMAG platform (Bio-
mérieux) following the standard protocol. Microbial genomic DNA was
used at a concentration of 5 ng/μl in 10 mM Tris (pH 8.5) for the Il-
lumina protocol for 16S rRNA gene Metagenomic Sequencing Library
Preparation (Cod. 15044223 Rev. A). PCR primers targeting the 16S
rRNA gene V3 and V4 regions were designed as in Klindworth et al.
(2013). Primer sequences are: Forward 5′TCGTCGGCAGCGTCAGATG-
TGTATAAGAGACAGCCTACGGGNGGCWGCA-G3′ and Reverse 5′GTCT
CGTGGGCTCGGAGATGTGTATAAGAGACAGGACTA-CHVGGGTATCT-
AATCC3′. Primers contained adapter overhang sequences added to the
gene-specific sequences, making them compatible with the Illumina
Nextera XT Index kit (FC-131-1096). After 16S rRNA gene amplifica-
tion, amplicons were multiplexed and 1 ml of amplicon pool was run on
a Bioanalyzer DNA 1000 chip to verify amplicon size (~550 bp). After
size verification, libraries were sequenced in an Illumina MiSeq se-
quencer according to manufacturer’s instructions in a 2x300 cycles
paired-end run (MiSeq Reagent kit v3 MS-102-3001).
2.9. Bioinformatic analysis
Quality assessment of sequencing reads was performed with the
prinseq-lite program (Schmieder & Edwards, 2011) applying the fol-
lowing parameters: a minimal length (min_length) of 50 nt and a
quality score threshold of 30 from the 3′-end (trim_qual_right), using a
mean quality score (trim_qual_type) calculated with a sliding window of
10 nucleotides (trim_qual_window). Read 1 and read 2 from Illumina
sequencing where joined using fastq-join from the ea-tools suite
(Aronesty, 2011). Taxonomic affiliations were assigned using the
RDP_classifier (Cole et al., 2009) from the Ribosomal Database Project
(RDP). Reads that had an RDP score below 0.8 were assigned to the next
higher taxonomic rank, leaving the last rank as unidentified. Six taxo-
nomic levels were assigned, which were kingdom, phylum, class, order,
family and genus.
2.10. Lactobacillus rhamnosus HN001 qPCR
The HN001 primer sequences used were Forward 5′-CGCTTAGGA
CTCAGGATACA-3′ and Reverse 5′-GCTTGCGTCAGATTTTCAGTA-3′,
according to published sequences (GenBank acc no.
NZ_ABWJ00000000). PCR conditions used to amplify fecal DNA tem-
plates were pre-incubation at 95 °C for 10 min; followed by 45 cycles of
denaturation at 95 °C for 10 s, annealing (69 °C) for 10 s and extension
at 72 °C for 30 s; with a final cooling at 40 °C for 30 s. DNA amplifi-
cation products were analysed with the QIAxcel System (QIAGEN,
Hilden, Germany).
2.11. Statistical analysis
The homogeneity of variance was assessed using the Levene test and
the normal distribution of the samples with the Shapiro-Wilk test. The
Student’s t-test was used to analyze parametric data. The significance
level was set at 5% (p < 0.05) in all tests. SPSS 22.0 for Windows (IBM
SPSS Inc., New York, USA) was used for data analyses.
3. Results and discussion
3.1. Anthropometric analysis
No significant differences in anthropometric parameters were de-
tected in the control group after 4 weeks consuming the salami control
(Supplemental Fig. S2A). In this case, results yield some interesting
conclusions since regular salami consumption did not modify BMI
index, weight, body fat percentage, or any skin-fold thickness mea-
surement. Therefore, at least in relation with anthropometric mea-
surements, daily salami intake does not translate in weight gain or in-
crease of body fat percentage (Fig. S2A).
Similar results were observed for the intervention group, no sig-
nificant differences were detected in any of the studied parameters after
4 weeks consuming the improved salami (Fig. S2B). In addition, no
statistically significant differences were found between the control and
intervention groups at the post-intervention time (p > 0.05) for any of
the assessed parameters. From these results it can be concluded that the
improved formulation (fiber, probiotic) does not have any effect on
body composition, at least at the dose administered. Accordingly, our
results showed that salami consumption with either of the two for-
mulations could be part of the diet without affecting anthropometric
parameters, contrary to the general perception about the unhealthy
effects of salami (Martínez et al., 2014). This conclusion was reached
after 4 weeks of salami intake, so the effect of a much longer intake
could be different and should be analyzed in future studies.
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3.2. Blood biochemistry
Salami consumption by the control group (Fig. S3A) did not change
the levels of plasmatic lipids (total cholesterol, LDLc, HDLc or TG).
These results suggest that regular salami can be part of a varied diet
without influencing plasmatic lipids. However, since this trial was
carried out with healthy volunteers and plasmatic lipids within the
normal range, these results cannot be extrapolated to people with an
unbalanced lipid profile and more experiments should be done in this
population. Regarding the rest of the biochemical parameters (i.e. he-
matology and leukocyte formula), no significant differences were de-
tected either. Therefore, it can be concluded here that regular salami
consumption does not affect blood biochemistry, at least in healthy
subjects during a 4 weeks period intake.
Regarding the intervention group, the results were in the same line
as in the control group (Fig. S3B). Plasmatic lipids did not change
significantly although a tendency to increase HDL levels (p = 0.069)
and to decrease LDL concentration (p = 0.058) was detected. Jahreis
et al. (2002) also found no modification is plasmatic lipid profile after
consumption of sausages fermented with a probiotic strain (Jahreis
et al., 2002). However, in our case the tendencies found could be de-
rived from the presence of fiber, which is known to decrease blood LDL
(Olmedilla-Alonso et al., 2013). Therefore, although the new in-
gredients added, at least at such dose, were not able to improve blood
parameters, they didn’t worsen them and tended to improve the lipid
profile, indicating that future experiments with a larger population are
needed.
3.3. Antioxidant capacity
To study the influence of salami intake, either control or interven-
tion salami, on body antioxidant status we analyzed the fecal anti-
oxidant capacity with the FRAP assay (Fig. 1A), and plasma antioxidant
capacity through plasmatic GPX, catalase, Ox-LDL and MDA (Fig. 1B
and C). Within the control group, no significant differences in any of the
parameters measured were found, suggesting that incorporating salami
to a varied diet neither increases nor decreases the redox status of the
subject. The levels of MDA, catalase and GPX were in the same range as
those reported for an adult population of the same body mass index
(Olusi, 2002).
On the other hand, regarding the intervention group, the anti-
oxidant capacity of feces did not show any changes before and after the
intervention period, although there was a tendency (p = 0.066) to
increase (Fig. 1A). However, plasmatic markers improved after the
4 weeks of intervention. In fact, GPX and catalase activity increased
significantly (p < 0.05) whereas Ox-LDL and MDA decreased sig-
nificantly (p < 0.05), suggesting a positive modulation of the redox
status (Fig. 1B and C). In fact, MDA levels were below the usual range
reported for individuals of the same body mass index (Olusi, 2002).
This beneficial modulation could be due to the antioxidant extract in-
corporated to salami, since it has been demonstrated that com-
plementing diet with antioxidants increases the expression of plasmatic
antioxidant enzymes (Alshammari, Balakrishnan, & Al-Khalifa, 2017).
Another possible explanation is a role of the added fiber. As our pre-
vious research showed in vitro salami added with this fiber showed a
great potential as an antioxidant, probably due to fiber composition as
well as to fiber metabolization by gut microbes (Pérez-Burillo et al.,
2019). Thus, the antioxidant species released, either from the fiber
matrix or from microbes’ metabolic activity, could be absorbed at the
large intestine and thus modulate the antioxidant status of plasma.
3.4. Inflammatory and immunological markers
Several markers involved in inflammation and immunological status
were measured: CRP, IL-6, IL-10, TNFα and phagocytic activity. CRP is
an unspecific inflammation marker that increases during inflammatory
processes, IL-6 and TNFα behave as pro-inflammatory species while IL-
10 is an anti-inflammatory interleukin. Inflammatory markers tested
did not change significantly within the control group after the 4 weeks
intake period (Fig. 2).
On the other hand, the intervention group showed an improvement
in their inflammatory status after the intake period. A significant de-
crease (p < 0.05) was detected in the levels of CRP and TNFα, sug-
gesting a less inflammatory environment (Fig. 2). The rest of the
parameters did not change significantly. These results could be due to
the improved formulation, including the probiotic bacteria and the fiber
component. For example, an improvement of the inflammatory and
immunological status has been demonstrated previously in elderly
people supplemented with the immunostimulatory probiotic strain L.
rhamnosus HN001 (Gill & Rutherfurd, 2001). However, it is known that
modifications in phagocytic activity are only found in elderly popula-
tion but not in adult population after exposure to a probiotic strain (Gill
& Rutherfurd, 2001). In addition, as it will be explained below, butyrate
levels were significantly (p < 0.05) increased in the intervention
group after the intake period. This SCFA has been previously related to
anti-inflammatory processes (Donohoe et al., 2014), being therefore
another possible reason for the improved inflammatory status of vo-
lunteers, in addition to the probiotic strain used for the fermentation
process.
3.5. Short chain fatty acids
Several health effects are attributed to SCFAs. Decreasing the lu-
minal pH is the obvious effect. The three main SCFAs (acetate, pro-
pionate and butyrate) are all important for the maintenance of the gut
barrier (Ríos-Covián et al., 2016). Moreover, while butyric acid is
mostly metabolized by colonocytes as a source of energy and carbon,
acetate and propionate are mainly absorbed and incorporated into
different metabolic routes, which in turn could link the control of me-
tabolic syndrome and diet-induced obesity (Lin et al., 2012). SCFAs also
have an important role in colorectal cancer protection (Donohoe et al.,
2014). In fact, it has been suggested that the protective effect of dietary
fiber against colorectal cancer depends upon the production of butyrate
and other SCFAs.
Regarding the control group no significant changes were detected
after the intake period; in fact, SCFAs levels were almost the same be-
fore and after (Fig. 3). Acetate, propionate and butyrate production
barely changed. On the other hand, within the intervention group,
acetate production tended to increase (p = 0.063) after the intake
period. In addition, there was a statistically significant increase
(p < 0.05) on butyrate levels after intervention (Fig. 3). This result
could explain, at least partially, why some inflammatory markers im-
proved after consumption of the re-formulated salami. This higher
butyrate production could be attributed to the fiber component of the
new formulation. As it has been previously demonstrated (Flint,
Duncan, Scott, & Louis, 2015), polysaccharide degradation leads to
butyrate production, being Faecalibacterium and Eubacterium the most
abundant butyrate producers in the human gut. As stated above, this
new salami formulation is based on a previous in vitro study in which
we investigated the potential of different fibers to produce SCFA (Pérez-
Burillo et al., 2019). As citrus fiber was the most promising agent, we
kept using it for the present formulation. As our previous research
showed (Pérez-Burillo et al., 2019), results after intervention suggest
that citrus fiber is also able to favor butyrate production. Higher bu-
tyrate production could be due to higher abundances for those genera
known to be butyrate producers, with Faecalibacterium, Eubacterium,
Roseburia, Anaerostipes, Coprococcus, Butyricimonas, Clostridium XIVa,
Intestinimonas and Butyricicoccus as their major representatives (Flint
et al., 2015; Ríos-Covián et al., 2016).
After analyzing gut microbial community structure by 16S rRNA, we
checked these genera to study whether their abundance was higher
after intervention, and to compare the control Vs. intervention group.
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No significant differences were found before and after salami intake,
neither in control nor in intervention group. However, in the inter-
vention group some not statistically significant increases in the abun-
dance of these genera were detected after salami intake:
Faecalibacterium, Eubacterium, Anaerostipes, Coprococcus, Butyricimonas,
Clostridium XIVa, and Intestinimonas. Even though these increases were
not significant, their synergic action could led to a significantly
(p < 0.05) higher butyrate production after salami consumption due
to the sum of butyrate producers: Faecalibacterium, Eubacterium,
Roseburia, Anaerostipes, Coprococcus, Butyricimononas, Clostridium XVIa,
Intestinimonas, Butyricicoccus (Fig. S4). Moreover, after checking for
Spearman correlations between butyrate concentrations and butyrate-
producers abundance, we found a positive significant correlation be-
tween butyrate and Clostridium XIVa (r2 = 0.57), Faecalibacterium
(r2 = 0.46) and total butyrate producers (r2 = 0.65). These correlations
were not found in the control group, reinforcing the idea that the im-
proved salami slightly modifies the functionality of the gut microbiota
so that it produces higher concentrations of healthy SCFAs.
Fig. 1. Panel A shows antioxidant capacity of volunteers’s feces measured by the FRAP method. Panel B shows plasmatic antioxidant markers GPx (μmol/min/ml),
Catalase (μmol/min/ml), and oxydized LDL (mU/L). Panel C shows MDA plasmatic levels. Statistical significance: *: p < 0.05, **: p < 0.01, ***: p < 0.001, ns:
not significant. PRE: before salami consumption, POST: after salami consumption. Statistical significance is shown for tests that used PRE as the reference group.
Analyses were carried out in triplicate.
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3.6. Gut microbial community structure
At phylum level, no significant differences between pre- and post-
intervention were found, neither in the control nor in the intervention
group (Fig. 4). After studying the community dissimilarity before and
after salami intake through PCoA based on the Unifrac phylogenetic
distance (Lozupone & Knight, 2005), no significant differences between
both groups were found, showing no clear separation in the PCoA plot
(Fig. 5A–B). At genus level, after applying OPLS-DA to investigate
discriminant bacteria in each group before and after salami intake, we
did not find any genus significantly associated to one or the other
group. LefSE analysis was also applied (Segata et al., 2011), but again
no significant differences were found. However, as stated before, some
tendencies where discovered when investigating butyrate producers,
and some of these bacteria were found to be higher (not significantly)
after improved salami intake. These results are in line with those re-
ported by other authors who found that the administration of different
foods enriched in different L. ramhnosus strains did not modify the
overall fecal microbiota, with slight modifications in the lactobacilli
populations (Lahtinen et al., 2012).
Gut microbial community alpha diversity was also investigated
through Shannon and Simpson indexes. As our previous analysis
suggested, no significant differences were found, showing a very similar
diversity before and after salami intake. Therefore, salami intake does
not have any significant influence on gut microbiota community
structure, at least in healthy people. However, though not significant,
improved salami intake did result in a significantly higher butyrate
production, probably due to some increase in certain butyrate produ-
cers.
3.7. qPCR Lactobacillus rhamnosus HN001
In order to classify a bacterial as a probiotic strain, one of the first
conditions is to survive in the gastrointestinal tract in sufficient num-
bers to exert a positive health effect in the host (Saxelin et al., 2010). In
general, 108–10 bacterial cells/day has been recommended as the
minimum number of a probiotic strain to provide a beneficial effect in
humans (Champagne, Ross, Saarela, Hansen, & Charalampopoulos,
2011). In the case of the probiotic salami, about 4–58 bacterial cells/g
were obtained (Table 1), so that the consumption of 30 g/day poten-
tially provides sufficient numbers of L. rhamnosus cells to obtain a
health effect.
A probiotic strain not only should be viable in a food product but it
also must survive the passage through the gastrointestinal tract (reach
Fig. 2. Plasmatic levels of inflammatory markers CRP (mg/L), TNFα (pg/mL), IL-6 (pg/mL), and IL-10 (pg/mL). Statistical significance: *: p < 0.05, **: p < 0.01,
***: p < 0.001, ns: not significant. PRE: before salami consumption, POST: after salami consumption. Statistical significance is shown for tests that used PRE as the
reference group. Analyses were carried out in triplicate.
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in a viable state the large and short intestine) in order to exert a positive
effect on the host health (Dommels et al., 2009). Therefore, it is ne-
cessary to analyze the presence of the probiotic strain in human fecal
samples. In this sense, L. rhamnosus was absent in all volunteers (both
control and intervention groups) during the run-in phase. Then, after
the intervention with probiotic salami, L. rhamnosus was detected in all
samples of the intervention group (but not in the control group), with
an average level of this species of log 6.78 cells/g. This level is similar
to those reported by other authors for L. rhamnosus in probiotic fer-
mented sausages (Rubio, Jofré, Aymerich, Guàrdia, & Garriga, 2014),
and cheese (Lahtinen et al., 2012).
4. Conclusions
As conclusions, whereas no changes were observed in anthropo-
metric measurements or blood biochemistry, reformulated salami im-
proved some inflammatory and immunological markers (CRP and
TNFα), antioxidant plasmatic markers and butyrate production.
Moreover, L. rhamnosus was found by qPCR in all volunteers’ feces from
the intervention group, suggesting that this probiotic was able to resist
passage through the gastrointestinal tract. As consequence, the pro-
biotic bacteria along with the added fiber component could be
responsible of the improved parameters observed. Accordingly, this
reformulated salami could be used as a substitute of regular salami in
common diets, or even included if not present, since it has no negative
effects, but rather it does the above mentioned parameters. However,
this trial has some limitations: i) it was carried out during four weeks,
so it could not be enough time for more significant effects on gut mi-
crobial community structure or some blood markers to show up; ii) only
24 individuals were studied and maybe with a larger court more sig-
nificant results would show; iii) volunteers court was composed of
healthy individuals, which could make detecting changes more chal-
lenging; iv) trials with individuals suffering from bowel inflammation
would be needed to assert the positive effects of enriched salami on
inflammation.
5. Ethics statement
The study complied with the principles of the declaration of
Helsinki. The Ethics Committee of the University of Granada approved
the study protocol, and informed consent was obtained from all parti-
cipants.
Fig. 3. Short chain fatty acids levels measured in volunteers’s feces. Statistical significance: *: p < 0.05, **: p < 0.01, ***: p < 0.001, ns: not significant. PRE:
before salami consumption, POST: after salami consumption. Statistical significance is shown for tests that used PRE as the reference group. Analyses were carried out
in triplicate.
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